Vagulienė, N. (2020) “THE PEMBREIZH MULTICENTER REAL-LIFE COHORT STUDY: FIRST LINE PEMBROLIZUMAB FOR NON-SMALL CELL LUNG CANCER PATIENTS WITH PD-L1 ≥50%”, Pulmonology and allergology, 4(2), pp. 164-167. doi: 10.37499/PIA.119.